It is the second day of MEDIA. HymonBio’s booth remains just as popular, with brilliant innovative achievements.
As the exhibition continues, the company’s Pan-Cancer Screening Kit has gartered more attention from international partners.
The Pan-Cancer Screening Test Kit analysis more than 400 gene methylation on the PCR platform. With only one tube of blood, it can detect up to 28 types of cancers. Its excellent performance can help detect cancer 3 to 5 years in advance. The key to cancer prevention lies in early detection, early treatment, and early intervention, with some cure rate reaching over 90%. The new test kit undoubtedly brought forth a new dawn and hope to the field of cancer research.
On that day, the marketing team had in-depth discussions on cooperation intentions with many internationally renowned medical companies, including technical cooperation, joint research and development, and locked in a series of promising cooperation directions.
For the next two days, HymonBio will be at Booth 1G38-1, awaiting your arrival!
Post time: Nov-13-2024